Computational modeling of cyclic peptide inhibitor-MDM2/MDMX binding through global docking and gaussian accelerated molecular dynamics simulations.

MDM2 and MDMX are potential targets for p53-dependent cancer therapy. Peptides are key in cellular immunology and oncology, and cyclic peptides generally have higher half-life than their linear cou...